Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease

Introduction and objectives: Clinical guidelines recommend specific drugs for type 2 diabetes (T2D), hypertension, and dyslipidemia in patients with non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH). We aimed to investigate the differences in prescription trends o...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2022-07-01
Serija:	Annals of Hepatology
Teme:	Antidiabetic drug Antihypertensive drug Lipid-lowering drug Clinical guideline Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1665268122000412
Oznake:	Označite Brez oznak, prvi označite!